Flexor tendon repair and reconstruction using live autografts often results in post-operative adhesions that limit joint flexion. To study this problem, we recently developed a mouse distal flexor digitorum longus (FDL) tendon grafting model in which a 3 mm intercalary live autograft or freeze-dried allograft is implanted [1]. We demonstrated that both autografts and allografts were equivalent in reductions of metatarsophalangeal (MTP) joint flexion due to adhesion and in their biomechanical properties, suggesting that allografts are a potentially attractive alternative to live autografts. Interestingly, we also observed that delayed improvements in MTP joint flexion followed peak Gdf5 gene expression, suggesting a role for GDF-5 in the remodeling necessary for functional improvements. We therefore hypothesized that loading freeze-dried mouse FDL tendon allografts with recombinant adeno-associated vector (rAAV) expressing Gdf5 gene will improve the functional properties of the reconstructed tendon and abolish adhesions.
Introduction:
Flexor tendon repair and reconstruction using live autografts often results in post-operative adhesions that limit joint flexion. To study this problem, we recently developed a mouse distal flexor digitorum longus (FDL) tendon grafting model in which a 3 mm intercalary live autograft or freeze-dried allograft is implanted [1] . We demonstrated that both autografts and allografts were equivalent in reductions of metatarsophalangeal (MTP) joint flexion due to adhesion and in their biomechanical properties, suggesting that allografts are a potentially attractive alternative to live autografts. Interestingly, we also observed that delayed improvements in MTP joint flexion followed peak Gdf5 gene expression, suggesting a role for GDF-5 in the remodeling necessary for functional improvements. We therefore hypothesized that loading freeze-dried mouse FDL tendon allografts with recombinant adeno-associated vector (rAAV) expressing Gdf5 gene will improve the functional properties of the reconstructed tendon and abolish adhesions.
Materials and Methods: Allograft Processing: Mouse FDL tendon allografts were freeze-dried, then reconstituted with rAAV solution (5×10 9 particles) expressing firefly luciferase gene (Luc), lacZ reporter gene, or Gdf5. Animal Surgeries: Distal FDL tendons of C57Bl6 mice were grafted with freeze-dried allografts loaded with rAAV as previously described [1] . In Vivo Bioluminescent Imaging (BLI): Freeze-dried FDL tendon allografts were loaded with rAAV-Luc (the firefly luciferase reporter gene) as described above and then implanted in the left FDL tendons of 4 mice. The mice were imaged on days 3, 7, 14, and 21 post grafting using a real-time bioluminescent imaging (BLI) system (IVIS® 100). Adhesions and Biomechanical Testing: Animals grafted with freeze-dried FDL allografts loaded with rAAV-lacZ (n=9) or rAAV-Gdf5 (n=9) were sacrificed at 14 & 28 days post implantation and the grafted hind limbs were evaluated to assess the flexion ROM of the MTP joint and the tensile biomechanical properties of the grafted FDL tendons [1] .
Results: To determine the kinetics and biodistribution of the tendon allograftmediated gene delivery in vivo, allografts loaded with rAAV-Luc were implanted in mouse FDL defects and demostrated a transient BLI signal localized at the implant site that peaked by 7 days and declined afterwards.
More importantly, rAAV-Gdf5 loaded allografts had significantly improved range of MTP joint flexion compared to lacZ controls (p<0.05) at 14 and 28 days post operatively. There were also trends of increased tensile mechanical properties (maximum force and stiffness) over time but there were no significant differences between the Gdf5 and lacZ treated grafts. Immunohistochemistry confirmed that the rAAV-transduced local expression of Gdf5 gene translates to GDF-5 protein synthesis by the host cells at the trated graft site which was lacking in lacZ controls.
Discussion: Given our previous findings that freeze-dried tendon allografts appear to have been tolerated well in the host mouse and provided biomechanical scaffolding functions equivalent to those afforded by live autografts, we examined whether allografts can serve as therapeutic delivery scaffolds to mediate adhesionfree reconstruction of flexor tendon gap defects. Our data show that despite modest retention efficiency (~10% as determined by real-time PCR), freeze-dried FDL allografts loaded with rAAV-Gdf5 resulted in local synthesis of the GDF-5 protein at 14 days that was associated with significantly improved range of flexion compared to rAAV-lacZ controls. Based on these findings, we propose a simplified alternative paradigm in tissue engineering in which freeze-dried allograft tissue can be used to deliver cues to the host cells in situ to reprogram the repair response. Freeze-dried tendon allografts can provide these delivery functions with a number of desirable characteristics over synthetic and naturally derived biomaterials, the most important of which is their remarkable native hydrophilic properties that permit efficient reconstitution of the tissue in a physiologic solution containing therapeutic molecules or delivery vehicles. This concept could be applied to other tendon and ligament models. Future development could also focus on differential processing (multiple genes and proteins) of composite allograft tissue (bone-tendonbone) to address clinically challenging problems such as soft tissue insertion into bone.
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